Alumni, Life Science & MedTech

Merylo

mEryLo’ is developing a compact microfluidic device, designed to trap drugs into the patient Red Blood Cells (RBCs) in a fast, easy and efficient way, preserving the cells membrane integrity. The use of cells as carriers of patient-specific drug cocktails will prolong the presence of the therapeutic agent circulating in the body, allowing for a lower frequency of the therapy and a reduction of the side effects. The device can be inserted in the standard clinical chemotherapy, but in a more tolerable version.

mEryLo’ is developing a compact microfluidic device, designed to trap drugs into the patient Red Blood Cells (RBCs) in a fast, easy and efficient way, preserving the cells membrane integrity. The use of cells as carriers of patient-specific drug cocktails will prolong the presence of the therapeutic agent circulating in the body, allowing for a lower frequency of the therapy and a reduction of the side effects. The device can be inserted in the standard clinical chemotherapy, but in a more tolerable version.